Literature DB >> 1139072

The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

P H Kelly, R J Miller.   

Abstract

1. The effect of muscarinic and neuroleptic agents on the turning behaviour induced by methamphetamine and apomorphine in rats with unilateral lesions of the substantia nigra induced by 6-hydroxydopamine has been examined. 2. Turning towards the side of the lesion induced by (+)-methamphetamine (5 mg/kg) was inhibited by alpha-flupenthixol (1 mg/kg) and alpha-clopenthixol (8 mg/kg) but not by high doses of their beta-isomers. 3. Turning was inhibited by chlorpromazine (4 mg/kg) and pimozide (0.2 mg/kg). Thioridazine and clozapine (16 mg/kg) were ineffective. Turning in the same direction produced by scopolamine (10 mg/kg) was also inhibited by alpha-flupenthixol (1 mg/kg) and pimozide (0.25 mg/kg). 4. Turning produced by methamphetamine (5 mg/kg) was inhibited by oxotremorine (0.75 mg/kg) even in the presence of methylatropine (5 mg/kg). 5. Turning away from the side of the lesion induced by apomorphine (0.1 mg/kg) was inhibited by oxotremorine (0.75 mg/kg) but not by thioridazine or clozapine (16 mg/kg). 6. These results are discussed with regard to the mode of action of neuroleptic drugs in producing anti-psychotic effects and drug-induced Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1139072      PMCID: PMC1666384          DOI: 10.1111/j.1476-5381.1975.tb07417.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Extrapyramidal side effects and clinical response to the phenothiazines.

Authors:  J O COLE; D J CLYDE
Journal:  Rev Can Biol       Date:  1961-06

2.  Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.

Authors:  H Stadler; K G Lloyd; M Gadea-Ciria; G Bartholini
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

Review 3.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

Authors:  O Hornykiewicz
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

4.  Dopamine antagonism and antischizophrenic potency of neuroleptic drugs.

Authors:  T J Crow; C Gillbe
Journal:  Nat New Biol       Date:  1973-09-05

5.  Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity.

Authors:  A S Horn; A C Cuello; R J Miller
Journal:  J Neurochem       Date:  1974-02       Impact factor: 5.372

6.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.

Authors:  N E Andén; S G Butcher; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

7.  Letter: Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys.

Authors:  K Shintomi; M Yamamura
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

8.  Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.

Authors:  R J Miller; C R Hiley
Journal:  Nature       Date:  1974-04-12       Impact factor: 49.962

Review 9.  Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.

Authors:  S Snyder; D Greenberg; H I Yamamura
Journal:  Arch Gen Psychiatry       Date:  1974-07

10.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

Authors:  Y C Clement-Cormier; J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

View more
  10 in total

Review 1.  Cholinergic functioning in stimulant addiction: implications for medications development.

Authors:  Mehmet Sofuoglu; Marc Mooney
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

2.  Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine.

Authors:  D J Boullin; R P Grimes
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

3.  Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.

Authors:  J L Bloss; G H Singer
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

4.  Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.

Authors:  D J Heal; A R Green; D J Boullin; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

5.  Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs.

Authors:  G Gianutsos
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

6.  Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation.

Authors:  S V Vellucci; D J Sirinathsinghji; P J Richardson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Pavlovian conditioning between co-administered drugs: elicitation of an apomorphine-induced antiparkinsonian response by scopolamine.

Authors:  R J Carey
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation.

Authors:  S J Brown; R Gill; J L Evenden; S D Iversen; P J Richardson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.

Authors:  P H Kelly; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

10.  Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice.

Authors:  P Worms; K Biziere
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.